

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.23470177 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.23470177 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.92351368 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.92351368 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.62117254 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.41769179 |
| 7 | behavioral response to nicotine (GO:0035095) | 6.36091545 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.10328581 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.10328581 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.10328581 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.94976554 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.87185726 |
| 13 | urea cycle (GO:0000050) | 5.72753666 |
| 14 | urea metabolic process (GO:0019627) | 5.72753666 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.72147410 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.53228321 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52598712 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.49731985 |
| 19 | cysteine metabolic process (GO:0006534) | 5.35455103 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.32024442 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.26750174 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 5.25582901 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.25157852 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.15776913 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.13968241 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.09325676 |
| 27 | protein carboxylation (GO:0018214) | 5.09325676 |
| 28 | bile acid metabolic process (GO:0008206) | 5.07093098 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 5.02146967 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.01564771 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 5.01451598 |
| 32 | regulation of complement activation (GO:0030449) | 4.93741175 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90508053 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.85065023 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.84517344 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.83156697 |
| 37 | phospholipid efflux (GO:0033700) | 4.77374130 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.76037174 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.76037174 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76037174 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.68095112 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.68095112 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.67265377 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.67265377 |
| 45 | bile acid and bile salt transport (GO:0015721) | 4.57960531 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.54058741 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.51532508 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.49912837 |
| 49 | imidazole-containing compound metabolic process (GO:0052803) | 4.48779359 |
| 50 | L-fucose catabolic process (GO:0042355) | 4.48494527 |
| 51 | fucose catabolic process (GO:0019317) | 4.48494527 |
| 52 | L-fucose metabolic process (GO:0042354) | 4.48494527 |
| 53 | lysine catabolic process (GO:0006554) | 4.47412227 |
| 54 | lysine metabolic process (GO:0006553) | 4.47412227 |
| 55 | glycine metabolic process (GO:0006544) | 4.40104764 |
| 56 | cholesterol efflux (GO:0033344) | 4.40089849 |
| 57 | drug catabolic process (GO:0042737) | 4.32979869 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.31050789 |
| 59 | cellular glucuronidation (GO:0052695) | 4.30712745 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.30052542 |
| 61 | regulation of bile acid biosynthetic process (GO:0070857) | 4.26896666 |
| 62 | amine catabolic process (GO:0009310) | 4.26135882 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.26135882 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.24168276 |
| 65 | intestinal cholesterol absorption (GO:0030299) | 4.23531116 |
| 66 | plasma lipoprotein particle assembly (GO:0034377) | 4.20695635 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 4.17431056 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.15849021 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.14969208 |
| 70 | glutamate metabolic process (GO:0006536) | 4.09272731 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 4.07901402 |
| 72 | ethanol oxidation (GO:0006069) | 4.06341037 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.05813550 |
| 74 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.05813550 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.01751402 |
| 76 | arginine metabolic process (GO:0006525) | 3.98218619 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 3.96881452 |
| 78 | cholesterol homeostasis (GO:0042632) | 3.94334845 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 3.88781622 |
| 80 | sterol homeostasis (GO:0055092) | 3.87950159 |
| 81 | response to pheromone (GO:0019236) | 3.85728260 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 3.81748852 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.81473605 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.81473605 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.81237445 |
| 86 | protein-lipid complex assembly (GO:0065005) | 3.79313999 |
| 87 | fibrinolysis (GO:0042730) | 3.78725588 |
| 88 | complement activation, classical pathway (GO:0006958) | 3.78672510 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.78092579 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.77556370 |
| 91 | phospholipid homeostasis (GO:0055091) | 3.74448877 |
| 92 | regulation of cholesterol homeostasis (GO:2000188) | 3.70268004 |
| 93 | complement activation (GO:0006956) | 3.69912962 |
| 94 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.69557484 |
| 95 | flavonoid metabolic process (GO:0009812) | 3.69280309 |
| 96 | cytolysis (GO:0019835) | 3.68652568 |
| 97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68483932 |
| 98 | cofactor catabolic process (GO:0051187) | 3.66363181 |
| 99 | exogenous drug catabolic process (GO:0042738) | 3.66306636 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.65758298 |
| 101 | organic acid catabolic process (GO:0016054) | 3.65704897 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.65704897 |
| 103 | epoxygenase P450 pathway (GO:0019373) | 3.64680757 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 3.63899246 |
| 105 | protein activation cascade (GO:0072376) | 3.63354460 |
| 106 | lipoprotein metabolic process (GO:0042157) | 3.61918985 |
| 107 | indole-containing compound metabolic process (GO:0042430) | 3.38862025 |
| 108 | sulfation (GO:0051923) | 3.33202916 |
| 109 | neuronal action potential (GO:0019228) | 3.24695120 |
| 110 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.20943256 |
| 111 | neural tube formation (GO:0001841) | 3.14815025 |
| 112 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.13698317 |
| 113 | detection of light stimulus involved in visual perception (GO:0050908) | 3.10421309 |
| 114 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.10421309 |
| 115 | negative regulation of telomere maintenance (GO:0032205) | 3.09366657 |
| 116 | reflex (GO:0060004) | 3.06612431 |
| 117 | platelet dense granule organization (GO:0060155) | 3.05278014 |
| 118 | piRNA metabolic process (GO:0034587) | 3.02372984 |
| 119 | ketone body metabolic process (GO:1902224) | 3.01271283 |
| 120 | protein K11-linked deubiquitination (GO:0035871) | 3.00415276 |
| 121 | behavioral response to ethanol (GO:0048149) | 2.99676608 |
| 122 | epithelial cilium movement (GO:0003351) | 2.96074887 |
| 123 | primary amino compound metabolic process (GO:1901160) | 2.95671280 |
| 124 | gamma-aminobutyric acid transport (GO:0015812) | 2.95348810 |
| 125 | protein localization to cilium (GO:0061512) | 2.95072721 |
| 126 | synaptic transmission, cholinergic (GO:0007271) | 2.94921588 |
| 127 | nonmotile primary cilium assembly (GO:0035058) | 2.94684046 |
| 128 | regulation of action potential (GO:0098900) | 2.91978273 |
| 129 | negative regulation of mast cell activation (GO:0033004) | 2.91612996 |
| 130 | kidney morphogenesis (GO:0060993) | 2.86709253 |
| 131 | protein polyglutamylation (GO:0018095) | 2.84967377 |
| 132 | transmission of nerve impulse (GO:0019226) | 2.84476720 |
| 133 | serotonin metabolic process (GO:0042428) | 2.80526382 |
| 134 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.79693626 |
| 135 | axoneme assembly (GO:0035082) | 2.77796138 |
| 136 | oxidative demethylation (GO:0070989) | 2.77035341 |
| 137 | cilium morphogenesis (GO:0060271) | 2.75385081 |
| 138 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.74464415 |
| 139 | DNA deamination (GO:0045006) | 2.74299282 |
| 140 | regulation of hexokinase activity (GO:1903299) | 2.73547661 |
| 141 | regulation of glucokinase activity (GO:0033131) | 2.73547661 |
| 142 | NAD biosynthetic process (GO:0009435) | 2.72456620 |
| 143 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.70653780 |
| 144 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.70653780 |
| 145 | NADH dehydrogenase complex assembly (GO:0010257) | 2.70653780 |
| 146 | cilium organization (GO:0044782) | 2.67430604 |
| 147 | multicellular organism reproduction (GO:0032504) | 2.62743127 |
| 148 | proline transport (GO:0015824) | 2.61538489 |
| 149 | cilium movement (GO:0003341) | 2.61425679 |
| 150 | cilium assembly (GO:0042384) | 2.59989565 |
| 151 | dopamine transport (GO:0015872) | 2.59609994 |
| 152 | retinal cone cell development (GO:0046549) | 2.58842090 |
| 153 | nephron epithelium morphogenesis (GO:0072088) | 2.57536750 |
| 154 | nephron tubule morphogenesis (GO:0072078) | 2.57536750 |
| 155 | photoreceptor cell maintenance (GO:0045494) | 2.56771174 |
| 156 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.56115204 |
| 157 | rRNA catabolic process (GO:0016075) | 2.53174758 |
| 158 | protein complex biogenesis (GO:0070271) | 2.53020001 |
| 159 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.51842947 |
| 160 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.50496650 |
| 161 | regulation of mesoderm development (GO:2000380) | 2.49957594 |
| 162 | action potential (GO:0001508) | 2.49845358 |
| 163 | auditory receptor cell stereocilium organization (GO:0060088) | 2.49754620 |
| 164 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.45950892 |
| 165 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.45707644 |
| 166 | signal peptide processing (GO:0006465) | 2.45434277 |
| 167 | nucleobase catabolic process (GO:0046113) | 2.45155938 |
| 168 | regulation of cilium movement (GO:0003352) | 2.44090392 |
| 169 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.43989307 |
| 170 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.43616921 |
| 171 | ubiquinone biosynthetic process (GO:0006744) | 2.41465614 |
| 172 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.41133984 |
| 173 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.41133984 |
| 174 | spinal cord motor neuron differentiation (GO:0021522) | 2.40988936 |
| 175 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.40168861 |
| 176 | rhodopsin mediated signaling pathway (GO:0016056) | 2.39398188 |
| 177 | DNA double-strand break processing (GO:0000729) | 2.38028616 |
| 178 | photoreceptor cell development (GO:0042461) | 2.37210073 |
| 179 | DNA methylation involved in gamete generation (GO:0043046) | 2.37047120 |
| 180 | reciprocal DNA recombination (GO:0035825) | 2.36623643 |
| 181 | reciprocal meiotic recombination (GO:0007131) | 2.36623643 |
| 182 | activated T cell proliferation (GO:0050798) | 2.35080858 |
| 183 | neuron fate determination (GO:0048664) | 2.34843404 |
| 184 | cornea development in camera-type eye (GO:0061303) | 2.34690826 |
| 185 | membrane depolarization during action potential (GO:0086010) | 2.34586156 |
| 186 | negative regulation by host of viral transcription (GO:0043922) | 2.34528256 |
| 187 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.34137292 |
| 188 | respiratory chain complex IV assembly (GO:0008535) | 2.32436748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.24031034 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18657534 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.15022796 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45553136 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.14817067 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.01844882 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.72349672 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03655523 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.99977492 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.91196306 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24651341 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 3.22956985 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.02195208 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.01900172 |
| 15 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.72315008 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.51023672 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.44472869 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38638486 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.37916174 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.37284566 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.22876135 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.20710737 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 2.16740520 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 2.12204942 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 2.03638813 |
| 26 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.02690478 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00783754 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7376973 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.93656762 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90124916 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.85482135 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75415523 |
| 33 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72599106 |
| 34 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.71470997 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.69281362 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.66253774 |
| 37 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65979223 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62224977 |
| 39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60083732 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.59444924 |
| 41 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57743516 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.57015800 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56210586 |
| 44 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.56170330 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55543833 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.55233623 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.55233623 |
| 48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.55171658 |
| 49 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54822109 |
| 50 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54496175 |
| 51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53260858 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53239553 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.53193206 |
| 54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.52449197 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.52389028 |
| 56 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51033043 |
| 57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.50424336 |
| 58 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.50348451 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49555072 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48936878 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47708444 |
| 62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46366611 |
| 63 | TCF4_23295773_ChIP-Seq_U87_Human | 1.44230328 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41526579 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.40962203 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.38023860 |
| 67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38023860 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35923778 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34930012 |
| 70 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34768369 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33702368 |
| 72 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33569475 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33032126 |
| 74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31293801 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31293801 |
| 76 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30781306 |
| 77 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.30484308 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.30423989 |
| 79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.28910944 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.28910944 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28210248 |
| 82 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.27930739 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25047604 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24942779 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24901347 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.24414643 |
| 87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23090220 |
| 88 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18793758 |
| 89 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17443372 |
| 90 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17184560 |
| 91 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15909395 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15606221 |
| 93 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.15375882 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14854345 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14703218 |
| 96 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13886419 |
| 97 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12964426 |
| 98 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12921383 |
| 99 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12911015 |
| 100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.12811606 |
| 101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10925384 |
| 102 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.10613863 |
| 103 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.10066274 |
| 104 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10053000 |
| 105 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07492165 |
| 106 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06368951 |
| 107 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06275228 |
| 108 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.05858459 |
| 109 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04221907 |
| 110 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03340968 |
| 111 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.03335233 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02747795 |
| 113 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01516672 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01511420 |
| 115 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01215011 |
| 116 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00585716 |
| 117 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99545193 |
| 118 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98685275 |
| 119 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97119882 |
| 120 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96688364 |
| 121 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95800453 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95546663 |
| 123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93022539 |
| 124 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91486735 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83421380 |
| 126 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83244317 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82642192 |
| 128 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80354415 |
| 129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80150305 |
| 130 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79225995 |
| 131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79052187 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78847753 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77659533 |
| 134 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77217030 |
| 135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76053576 |
| 136 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75969859 |
| 137 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.75508146 |
| 138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72670607 |
| 139 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70601519 |
| 140 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70400309 |
| 141 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69058876 |
| 142 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.68389533 |
| 143 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66144604 |
| 144 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66111543 |
| 145 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.65167297 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64149806 |
| 147 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64044391 |
| 148 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63751204 |
| 149 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.63286555 |
| 150 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60492985 |
| 151 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60294839 |
| 152 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60294839 |
| 153 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.60092364 |
| 154 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.59171175 |
| 155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59078096 |
| 156 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58315270 |
| 157 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58131830 |
| 158 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56227008 |
| 159 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55829866 |
| 160 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55685193 |
| 161 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55257617 |
| 162 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.55053530 |
| 163 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53223722 |
| 164 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52429244 |
| 165 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52329986 |
| 166 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.52285100 |
| 167 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49933610 |
| 168 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.49897228 |
| 169 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49823860 |
| 170 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47432553 |
| 171 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47014725 |
| 172 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46799129 |
| 173 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46614198 |
| 174 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46610970 |
| 175 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.44548558 |
| 176 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.43481772 |
| 177 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.43198898 |
| 178 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.42747859 |
| 179 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41284057 |
| 180 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.40501915 |
| 181 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40401820 |
| 182 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40332399 |
| 183 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.40158016 |
| 184 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39950845 |
| 185 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39760990 |
| 186 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39753799 |
| 187 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38635975 |
| 188 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.38165266 |
| 189 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.37899659 |
| 190 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37328464 |
| 191 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36977621 |
| 192 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.36933731 |
| 193 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36699542 |
| 194 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36404473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.29126203 |
| 2 | MP0005360_urolithiasis | 7.89661915 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.49070299 |
| 4 | MP0005365_abnormal_bile_salt | 6.10070249 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05486247 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.05277839 |
| 7 | MP0003252_abnormal_bile_duct | 4.03777482 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.56383409 |
| 9 | MP0009840_abnormal_foam_cell | 3.40432464 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.04541657 |
| 11 | MP0005083_abnormal_biliary_tract | 2.84914780 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.69810812 |
| 13 | MP0005332_abnormal_amino_acid | 2.67884282 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.56931808 |
| 15 | MP0003195_calcinosis | 2.56879501 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 2.48564242 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.34459471 |
| 18 | MP0002102_abnormal_ear_morphology | 2.31794289 |
| 19 | MP0009046_muscle_twitch | 2.21484233 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.20891528 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.18985101 |
| 22 | MP0003136_yellow_coat_color | 2.18874400 |
| 23 | MP0009745_abnormal_behavioral_response | 2.14954198 |
| 24 | MP0000609_abnormal_liver_physiology | 2.14298207 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.12877810 |
| 26 | MP0002653_abnormal_ependyma_morphology | 2.07728759 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.07692762 |
| 28 | MP0002638_abnormal_pupillary_reflex | 2.06246614 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 2.02126660 |
| 30 | MP0002736_abnormal_nociception_after | 1.94028628 |
| 31 | MP0003868_abnormal_feces_composition | 1.92934263 |
| 32 | MP0004142_abnormal_muscle_tone | 1.89990573 |
| 33 | MP0003646_muscle_fatigue | 1.88218151 |
| 34 | MP0004043_abnormal_pH_regulation | 1.86747510 |
| 35 | MP0001485_abnormal_pinna_reflex | 1.85270975 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 1.81500982 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.81377936 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.79681318 |
| 39 | MP0002272_abnormal_nervous_system | 1.76075741 |
| 40 | MP0004147_increased_porphyrin_level | 1.75954424 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.73538034 |
| 42 | MP0002064_seizures | 1.73095024 |
| 43 | MP0001764_abnormal_homeostasis | 1.69849337 |
| 44 | MP0005253_abnormal_eye_physiology | 1.68537343 |
| 45 | MP0009697_abnormal_copulation | 1.66431755 |
| 46 | MP0003787_abnormal_imprinting | 1.63969273 |
| 47 | MP0003880_abnormal_central_pattern | 1.62772130 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.62252870 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.61099358 |
| 50 | MP0004885_abnormal_endolymph | 1.60079156 |
| 51 | MP0002572_abnormal_emotion/affect_behav | 1.59932337 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.57345475 |
| 53 | MP0001486_abnormal_startle_reflex | 1.57232398 |
| 54 | MP0005451_abnormal_body_composition | 1.48985297 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.48207096 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.47264725 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.45741512 |
| 58 | MP0001970_abnormal_pain_threshold | 1.44437177 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43535367 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.43436306 |
| 61 | MP0004133_heterotaxia | 1.41344781 |
| 62 | MP0004742_abnormal_vestibular_system | 1.36960927 |
| 63 | MP0002938_white_spotting | 1.33106840 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.31754744 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.30837135 |
| 66 | MP0000372_irregular_coat_pigmentation | 1.30726906 |
| 67 | MP0005647_abnormal_sex_gland | 1.30054087 |
| 68 | MP0002254_reproductive_system_inflammat | 1.29130761 |
| 69 | MP0001984_abnormal_olfaction | 1.27267561 |
| 70 | MP0009643_abnormal_urine_homeostasis | 1.25761896 |
| 71 | MP0001529_abnormal_vocalization | 1.25272085 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.24419018 |
| 73 | MP0004924_abnormal_behavior | 1.24419018 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 1.24316729 |
| 75 | MP0000383_abnormal_hair_follicle | 1.22209828 |
| 76 | MP0003011_delayed_dark_adaptation | 1.22152185 |
| 77 | MP0003635_abnormal_synaptic_transmissio | 1.19111436 |
| 78 | MP0005410_abnormal_fertilization | 1.17891157 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.17359480 |
| 80 | MP0002063_abnormal_learning/memory/cond | 1.16435135 |
| 81 | MP0000598_abnormal_liver_morphology | 1.14322683 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 1.13016188 |
| 83 | MP0003186_abnormal_redox_activity | 1.12841207 |
| 84 | MP0004215_abnormal_myocardial_fiber | 1.10311172 |
| 85 | MP0005195_abnormal_posterior_eye | 1.08821834 |
| 86 | MP0006292_abnormal_olfactory_placode | 1.08791164 |
| 87 | MP0002734_abnormal_mechanical_nocicepti | 1.07498534 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 1.06110781 |
| 89 | MP0009764_decreased_sensitivity_to | 1.04691800 |
| 90 | MP0003705_abnormal_hypodermis_morpholog | 1.03505087 |
| 91 | MP0002876_abnormal_thyroid_physiology | 1.02605377 |
| 92 | MP0005389_reproductive_system_phenotype | 1.02525072 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 1.02232131 |
| 94 | MP0003878_abnormal_ear_physiology | 1.02232131 |
| 95 | MP0002234_abnormal_pharynx_morphology | 1.00280081 |
| 96 | MP0001905_abnormal_dopamine_level | 0.97594468 |
| 97 | MP0002160_abnormal_reproductive_system | 0.96728982 |
| 98 | MP0001919_abnormal_reproductive_system | 0.95835321 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.95534447 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.95408175 |
| 101 | MP0009763_increased_sensitivity_to | 0.95332109 |
| 102 | MP0000604_amyloidosis | 0.94879173 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.94496809 |
| 104 | MP0000026_abnormal_inner_ear | 0.93706375 |
| 105 | MP0005174_abnormal_tail_pigmentation | 0.92924003 |
| 106 | MP0003890_abnormal_embryonic-extraembry | 0.92870719 |
| 107 | MP0001873_stomach_inflammation | 0.90082101 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 0.89691846 |
| 109 | MP0008469_abnormal_protein_level | 0.88672985 |
| 110 | MP0003698_abnormal_male_reproductive | 0.88459911 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.88371869 |
| 112 | MP0003119_abnormal_digestive_system | 0.88015263 |
| 113 | MP0000778_abnormal_nervous_system | 0.86677832 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.86454877 |
| 115 | MP0009642_abnormal_blood_homeostasis | 0.85018734 |
| 116 | MP0001963_abnormal_hearing_physiology | 0.84442284 |
| 117 | MP0002184_abnormal_innervation | 0.84419290 |
| 118 | MP0001664_abnormal_digestion | 0.83927478 |
| 119 | MP0001324_abnormal_eye_pigmentation | 0.82195750 |
| 120 | MP0002751_abnormal_autonomic_nervous | 0.80719572 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.80313119 |
| 122 | MP0005376_homeostasis/metabolism_phenot | 0.78550284 |
| 123 | MP0002229_neurodegeneration | 0.77224993 |
| 124 | MP0003283_abnormal_digestive_organ | 0.76899127 |
| 125 | MP0006036_abnormal_mitochondrial_physio | 0.76170729 |
| 126 | MP0005408_hypopigmentation | 0.75406679 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.75332045 |
| 128 | MP0005670_abnormal_white_adipose | 0.74299068 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.73898412 |
| 130 | MP0010368_abnormal_lymphatic_system | 0.73273786 |
| 131 | MP0005334_abnormal_fat_pad | 0.70990451 |
| 132 | MP0002971_abnormal_brown_adipose | 0.70892842 |
| 133 | MP0005266_abnormal_metabolism | 0.65921829 |
| 134 | MP0003718_maternal_effect | 0.65739784 |
| 135 | MP0005448_abnormal_energy_balance | 0.64755977 |
| 136 | MP0009053_abnormal_anal_canal | 0.64683552 |
| 137 | MP0005535_abnormal_body_temperature | 0.60754729 |
| 138 | MP0001661_extended_life_span | 0.59918485 |
| 139 | MP0001756_abnormal_urination | 0.58908201 |
| 140 | MP0002822_catalepsy | 0.55170805 |
| 141 | MP0004264_abnormal_extraembryonic_tissu | 0.54647636 |
| 142 | MP0003690_abnormal_glial_cell | 0.53670464 |
| 143 | MP0004130_abnormal_muscle_cell | 0.53063157 |
| 144 | MP0003329_amyloid_beta_deposits | 0.51507549 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.50654086 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.50525830 |
| 147 | MP0005395_other_phenotype | 0.49433944 |
| 148 | MP0002796_impaired_skin_barrier | 0.49396069 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.49183668 |
| 150 | MP0002136_abnormal_kidney_physiology | 0.48824896 |
| 151 | MP0000639_abnormal_adrenal_gland | 0.47653161 |
| 152 | MP0010234_abnormal_vibrissa_follicle | 0.46860207 |
| 153 | MP0004782_abnormal_surfactant_physiolog | 0.45461283 |
| 154 | MP0000579_abnormal_nail_morphology | 0.44424551 |
| 155 | MP0002928_abnormal_bile_duct | 0.43470202 |
| 156 | MP0008873_increased_physiological_sensi | 0.42882379 |
| 157 | MP0008872_abnormal_physiological_respon | 0.41614845 |
| 158 | MP0004381_abnormal_hair_follicle | 0.40622089 |
| 159 | MP0003953_abnormal_hormone_level | 0.40324109 |
| 160 | MP0009384_cardiac_valve_regurgitation | 0.40267469 |
| 161 | MP0005166_decreased_susceptibility_to | 0.39544781 |
| 162 | MP0006082_CNS_inflammation | 0.39169045 |
| 163 | MP0008874_decreased_physiological_sensi | 0.38596438 |
| 164 | MP0001881_abnormal_mammary_gland | 0.38399231 |
| 165 | MP0009115_abnormal_fat_cell | 0.36123835 |
| 166 | MP0003724_increased_susceptibility_to | 0.35680370 |
| 167 | MP0005666_abnormal_adipose_tissue | 0.34951366 |
| 168 | MP0003436_decreased_susceptibility_to | 0.34207141 |
| 169 | MP0009672_abnormal_birth_weight | 0.31207843 |
| 170 | MP0005248_abnormal_Harderian_gland | 0.30771415 |
| 171 | MP0001845_abnormal_inflammatory_respons | 0.30416498 |
| 172 | MP0000230_abnormal_systemic_arterial | 0.30039650 |
| 173 | MP0003075_altered_response_to | 0.29544653 |
| 174 | MP0003453_abnormal_keratinocyte_physiol | 0.28359894 |
| 175 | MP0002970_abnormal_white_adipose | 0.28286000 |
| 176 | MP0002132_abnormal_respiratory_system | 0.26579424 |
| 177 | MP0001853_heart_inflammation | 0.26085190 |
| 178 | MP0003300_gastrointestinal_ulcer | 0.25958118 |
| 179 | MP0000249_abnormal_blood_vessel | 0.25737272 |
| 180 | MP0000538_abnormal_urinary_bladder | 0.25526301 |
| 181 | MP0000427_abnormal_hair_cycle | 0.25076545 |
| 182 | MP0002060_abnormal_skin_morphology | 0.24904072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.40620483 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.06636117 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.00402404 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.74433495 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64933906 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.35898532 |
| 7 | Xanthomatosis (HP:0000991) | 6.25381427 |
| 8 | Complement deficiency (HP:0004431) | 5.38320785 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.24066536 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.87336806 |
| 11 | Epidermoid cyst (HP:0200040) | 4.60297426 |
| 12 | Hyperammonemia (HP:0001987) | 4.54813918 |
| 13 | Hyperglycinemia (HP:0002154) | 4.53194397 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.49243093 |
| 15 | Joint hemorrhage (HP:0005261) | 4.47371524 |
| 16 | Fat malabsorption (HP:0002630) | 4.46539385 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42220751 |
| 18 | Pancreatic cysts (HP:0001737) | 4.33988647 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.29568931 |
| 20 | Hyperglycinuria (HP:0003108) | 4.23956345 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.19194650 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15353152 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 4.11714046 |
| 24 | Congenital stationary night blindness (HP:0007642) | 4.11656845 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.09891990 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 4.09891990 |
| 27 | True hermaphroditism (HP:0010459) | 4.05406775 |
| 28 | Molar tooth sign on MRI (HP:0002419) | 4.05074852 |
| 29 | Abnormality of midbrain morphology (HP:0002418) | 4.05074852 |
| 30 | Pancreatic fibrosis (HP:0100732) | 4.04188685 |
| 31 | Ketosis (HP:0001946) | 4.01915854 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 3.98428489 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.98223991 |
| 34 | Abnormality of complement system (HP:0005339) | 3.96661242 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80042057 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.79518638 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71684310 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.66642702 |
| 39 | Hyperventilation (HP:0002883) | 3.57480358 |
| 40 | Nephronophthisis (HP:0000090) | 3.53339120 |
| 41 | Attenuation of retinal blood vessels (HP:0007843) | 3.42769088 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41837414 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.35041581 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 3.34740468 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33695507 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 3.29147606 |
| 47 | Hyperalaninemia (HP:0003348) | 3.29147606 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.29147606 |
| 49 | Steatorrhea (HP:0002570) | 3.23852442 |
| 50 | Acanthocytosis (HP:0001927) | 3.21195974 |
| 51 | Abolished electroretinogram (ERG) (HP:0000550) | 3.18466017 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 3.13631254 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 3.12553555 |
| 54 | Abnormality of the renal medulla (HP:0100957) | 2.99672122 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.98250502 |
| 56 | Type II lissencephaly (HP:0007260) | 2.95677804 |
| 57 | Ketoacidosis (HP:0001993) | 2.89961399 |
| 58 | Myocardial infarction (HP:0001658) | 2.87669779 |
| 59 | Delayed CNS myelination (HP:0002188) | 2.87198271 |
| 60 | Gait imbalance (HP:0002141) | 2.86893938 |
| 61 | Congenital, generalized hypertrichosis (HP:0004540) | 2.83766307 |
| 62 | Cystic liver disease (HP:0006706) | 2.83751294 |
| 63 | Spontaneous abortion (HP:0005268) | 2.83125551 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.81069563 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.78809303 |
| 66 | Skin nodule (HP:0200036) | 2.77011635 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.77002896 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.76578616 |
| 69 | Inability to walk (HP:0002540) | 2.76508688 |
| 70 | Metabolic acidosis (HP:0001942) | 2.75630967 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.72573107 |
| 72 | Chronic hepatic failure (HP:0100626) | 2.70749066 |
| 73 | Large for gestational age (HP:0001520) | 2.63076624 |
| 74 | Lethargy (HP:0001254) | 2.60011881 |
| 75 | Tubular atrophy (HP:0000092) | 2.58370663 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 2.57227475 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57227475 |
| 78 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.54786165 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.54546823 |
| 80 | Nephrogenic diabetes insipidus (HP:0009806) | 2.53741054 |
| 81 | Malnutrition (HP:0004395) | 2.53610896 |
| 82 | Vascular calcification (HP:0004934) | 2.51631522 |
| 83 | Protruding tongue (HP:0010808) | 2.51505875 |
| 84 | Decreased central vision (HP:0007663) | 2.49249579 |
| 85 | Poikilocytosis (HP:0004447) | 2.48379952 |
| 86 | Cholelithiasis (HP:0001081) | 2.48074395 |
| 87 | Progressive inability to walk (HP:0002505) | 2.47489837 |
| 88 | Polydipsia (HP:0001959) | 2.46815115 |
| 89 | Abnormal drinking behavior (HP:0030082) | 2.46815115 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46452129 |
| 91 | Gout (HP:0001997) | 2.45911770 |
| 92 | Pendular nystagmus (HP:0012043) | 2.45682847 |
| 93 | Decreased circulating renin level (HP:0003351) | 2.45513008 |
| 94 | Sclerocornea (HP:0000647) | 2.45322143 |
| 95 | Progressive cerebellar ataxia (HP:0002073) | 2.44391456 |
| 96 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.44083235 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.42857129 |
| 98 | Cholecystitis (HP:0001082) | 2.42857129 |
| 99 | Lissencephaly (HP:0001339) | 2.42377695 |
| 100 | Hypoglycemic seizures (HP:0002173) | 2.39722316 |
| 101 | Furrowed tongue (HP:0000221) | 2.39135388 |
| 102 | Birth length less than 3rd percentile (HP:0003561) | 2.36500352 |
| 103 | Spastic diplegia (HP:0001264) | 2.34142379 |
| 104 | Glomerulonephritis (HP:0000099) | 2.33561256 |
| 105 | Irritability (HP:0000737) | 2.32044701 |
| 106 | Cerebellar dysplasia (HP:0007033) | 2.27994270 |
| 107 | Absent/shortened dynein arms (HP:0200106) | 2.27722813 |
| 108 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.27722813 |
| 109 | Cerebral edema (HP:0002181) | 2.26485779 |
| 110 | Genital tract atresia (HP:0001827) | 2.25015890 |
| 111 | Mitral stenosis (HP:0001718) | 2.24156929 |
| 112 | Esophageal varix (HP:0002040) | 2.24108928 |
| 113 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.21848817 |
| 114 | Cardiovascular calcification (HP:0011915) | 2.21789757 |
| 115 | Male pseudohermaphroditism (HP:0000037) | 2.21085196 |
| 116 | Vaginal atresia (HP:0000148) | 2.17920941 |
| 117 | Gaze-evoked nystagmus (HP:0000640) | 2.17745624 |
| 118 | Broad-based gait (HP:0002136) | 2.17692619 |
| 119 | Neonatal onset (HP:0003623) | 2.16340558 |
| 120 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.16043254 |
| 121 | Amyloidosis (HP:0011034) | 2.16003918 |
| 122 | Fair hair (HP:0002286) | 2.15815768 |
| 123 | Sensorimotor neuropathy (HP:0007141) | 2.15768727 |
| 124 | Hydroxyprolinuria (HP:0003080) | 2.15174968 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 2.15174968 |
| 126 | Pancreatitis (HP:0001733) | 2.15083999 |
| 127 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.14038766 |
| 128 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.13273443 |
| 129 | Increased corneal curvature (HP:0100692) | 2.13158631 |
| 130 | Keratoconus (HP:0000563) | 2.13158631 |
| 131 | Genetic anticipation (HP:0003743) | 2.12114143 |
| 132 | Hemiparesis (HP:0001269) | 2.10703771 |
| 133 | Gingival bleeding (HP:0000225) | 2.09777528 |
| 134 | Brushfield spots (HP:0001088) | 2.09604793 |
| 135 | Concave nail (HP:0001598) | 2.09338659 |
| 136 | Anencephaly (HP:0002323) | 2.07186504 |
| 137 | Enlarged kidneys (HP:0000105) | 2.06393986 |
| 138 | Clumsiness (HP:0002312) | 2.06358058 |
| 139 | Late onset (HP:0003584) | 2.05726313 |
| 140 | Abnormality of the gallbladder (HP:0005264) | 2.05702224 |
| 141 | 3-Methylglutaconic aciduria (HP:0003535) | 2.04860904 |
| 142 | Focal motor seizures (HP:0011153) | 2.04313071 |
| 143 | Febrile seizures (HP:0002373) | 2.03580313 |
| 144 | Hypothermia (HP:0002045) | 2.02163161 |
| 145 | Patellar aplasia (HP:0006443) | 2.02037150 |
| 146 | Poor coordination (HP:0002370) | 2.01438427 |
| 147 | Congenital hepatic fibrosis (HP:0002612) | 2.01233067 |
| 148 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.99717841 |
| 149 | Menorrhagia (HP:0000132) | 1.99466197 |
| 150 | Hyperglycemia (HP:0003074) | 1.99220168 |
| 151 | Abnormality of the pons (HP:0007361) | 1.99181340 |
| 152 | Vomiting (HP:0002013) | 1.98898511 |
| 153 | Generalized aminoaciduria (HP:0002909) | 1.98799426 |
| 154 | Rickets (HP:0002748) | 1.98511798 |
| 155 | Opisthotonus (HP:0002179) | 1.97162140 |
| 156 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96305026 |
| 157 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.96189498 |
| 158 | Focal seizures (HP:0007359) | 1.95685836 |
| 159 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95267419 |
| 160 | Abnormal ciliary motility (HP:0012262) | 1.94269337 |
| 161 | Hemorrhage of the eye (HP:0011885) | 1.93958527 |
| 162 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.93100289 |
| 163 | Abnormal cartilage morphology (HP:0002763) | 1.92866404 |
| 164 | Thrombophlebitis (HP:0004418) | 1.92374142 |
| 165 | Reticulocytosis (HP:0001923) | 1.91959215 |
| 166 | Abnormality of vitamin metabolism (HP:0100508) | 1.91778095 |
| 167 | Postaxial foot polydactyly (HP:0001830) | 1.90717202 |
| 168 | Renal cortical cysts (HP:0000803) | 1.90675318 |
| 169 | Abnormality of iron homeostasis (HP:0011031) | 1.90394753 |
| 170 | Polyuria (HP:0000103) | 1.89712312 |
| 171 | Glycosuria (HP:0003076) | 1.89023960 |
| 172 | Abnormality of urine glucose concentration (HP:0011016) | 1.89023960 |
| 173 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88891586 |
| 174 | Pachygyria (HP:0001302) | 1.87125526 |
| 175 | Severe muscular hypotonia (HP:0006829) | 1.86404735 |
| 176 | Chorioretinal atrophy (HP:0000533) | 1.86106911 |
| 177 | Hypoplasia of the pons (HP:0012110) | 1.85157958 |
| 178 | Abnormality of macular pigmentation (HP:0008002) | 1.84945089 |
| 179 | Optic nerve hypoplasia (HP:0000609) | 1.82760861 |
| 180 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.81591190 |
| 181 | Hypoplasia of the fovea (HP:0007750) | 1.81591190 |
| 182 | Constricted visual fields (HP:0001133) | 1.79864372 |
| 183 | Bilateral microphthalmos (HP:0007633) | 1.79695247 |
| 184 | Elevated hepatic transaminases (HP:0002910) | 1.78925565 |
| 185 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.77423997 |
| 186 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.77423997 |
| 187 | Optic disc pallor (HP:0000543) | 1.77223156 |
| 188 | Proximal tubulopathy (HP:0000114) | 1.77036305 |
| 189 | Congenital sensorineural hearing impairment (HP:0008527) | 1.76474799 |
| 190 | Abnormal biliary tract physiology (HP:0012439) | 1.76197994 |
| 191 | Bile duct proliferation (HP:0001408) | 1.76197994 |
| 192 | Stomach cancer (HP:0012126) | 1.75752927 |
| 193 | Dialeptic seizures (HP:0011146) | 1.75463899 |
| 194 | Colon cancer (HP:0003003) | 1.75442419 |
| 195 | Increased CSF lactate (HP:0002490) | 1.73532934 |
| 196 | Partial agenesis of the corpus callosum (HP:0001338) | 1.73003108 |
| 197 | Retinitis pigmentosa (HP:0000510) | 1.72884706 |
| 198 | Generalized hypopigmentation of hair (HP:0011358) | 1.71205512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.65243951 |
| 2 | ERN1 | 4.32367790 |
| 3 | FGFR4 | 4.24406899 |
| 4 | SIK1 | 3.87386104 |
| 5 | BMPR1B | 3.57104735 |
| 6 | TAOK3 | 3.47440660 |
| 7 | ERBB4 | 3.36394686 |
| 8 | ADRBK2 | 3.01197769 |
| 9 | MST1R | 2.94457009 |
| 10 | WNK3 | 2.76391474 |
| 11 | FRK | 2.72182709 |
| 12 | INSRR | 2.71660462 |
| 13 | ACVR1B | 2.59605400 |
| 14 | WNK4 | 2.33722263 |
| 15 | ZAK | 2.30336648 |
| 16 | LATS1 | 2.17169269 |
| 17 | PNCK | 2.12521177 |
| 18 | MAP4K2 | 2.09836351 |
| 19 | MAPK11 | 2.07536519 |
| 20 | MAP2K4 | 2.03139584 |
| 21 | CASK | 1.99492244 |
| 22 | TLK1 | 1.97931990 |
| 23 | MAPK13 | 1.92744124 |
| 24 | OXSR1 | 1.83088960 |
| 25 | MAP3K4 | 1.81096648 |
| 26 | PIK3CG | 1.69341054 |
| 27 | TYK2 | 1.68410794 |
| 28 | PKN2 | 1.64857047 |
| 29 | NEK9 | 1.62399373 |
| 30 | CAMKK2 | 1.59186906 |
| 31 | STK39 | 1.58298269 |
| 32 | PTK6 | 1.54146494 |
| 33 | STK38L | 1.46179989 |
| 34 | MARK1 | 1.45923116 |
| 35 | ABL2 | 1.44639965 |
| 36 | GRK6 | 1.41880308 |
| 37 | IRAK3 | 1.41859181 |
| 38 | FLT3 | 1.41631682 |
| 39 | MKNK2 | 1.37024788 |
| 40 | TGFBR1 | 1.36537969 |
| 41 | MAP3K14 | 1.33578568 |
| 42 | TXK | 1.30841019 |
| 43 | PRKAA2 | 1.23966639 |
| 44 | TSSK6 | 1.23890282 |
| 45 | MAP3K3 | 1.21405007 |
| 46 | DAPK2 | 1.20855149 |
| 47 | PINK1 | 1.19577170 |
| 48 | TRIB3 | 1.19557280 |
| 49 | JAK2 | 1.19533773 |
| 50 | MAP2K7 | 1.18627325 |
| 51 | VRK1 | 1.13801492 |
| 52 | MAP3K7 | 1.13050211 |
| 53 | ERBB2 | 1.12496159 |
| 54 | TBK1 | 1.10986002 |
| 55 | ADRBK1 | 1.08209359 |
| 56 | FGFR2 | 1.06617160 |
| 57 | TNIK | 1.06615331 |
| 58 | EPHA2 | 1.06396214 |
| 59 | MAP3K11 | 1.05261893 |
| 60 | DYRK1B | 1.05063968 |
| 61 | KDR | 1.04610291 |
| 62 | MAPK15 | 1.02773378 |
| 63 | MAP3K10 | 1.02448335 |
| 64 | MAP2K3 | 0.99306609 |
| 65 | MET | 0.97905575 |
| 66 | NTRK3 | 0.97068240 |
| 67 | PRKCE | 0.93580446 |
| 68 | MAPK4 | 0.92957586 |
| 69 | JAK1 | 0.90577647 |
| 70 | MAPKAPK5 | 0.88983362 |
| 71 | MAPKAPK3 | 0.88197838 |
| 72 | PRKCZ | 0.87036074 |
| 73 | TRIM28 | 0.86231733 |
| 74 | MAP2K6 | 0.86129514 |
| 75 | DYRK2 | 0.84583504 |
| 76 | PTK2B | 0.84367918 |
| 77 | AKT3 | 0.81746406 |
| 78 | TAF1 | 0.81303184 |
| 79 | CSNK1G2 | 0.81096291 |
| 80 | CDK6 | 0.80101366 |
| 81 | WEE1 | 0.79969759 |
| 82 | CAMK2G | 0.78665812 |
| 83 | RIPK1 | 0.78026805 |
| 84 | EPHB1 | 0.76285042 |
| 85 | PRKAA1 | 0.74506728 |
| 86 | MKNK1 | 0.74260495 |
| 87 | PRKACG | 0.73759585 |
| 88 | EPHA3 | 0.73024838 |
| 89 | CSNK1G3 | 0.69931424 |
| 90 | PHKG2 | 0.68146627 |
| 91 | PHKG1 | 0.68146627 |
| 92 | MAP2K2 | 0.67875116 |
| 93 | BCR | 0.64251909 |
| 94 | GSK3A | 0.63497159 |
| 95 | RPS6KA5 | 0.62147772 |
| 96 | CAMK2A | 0.61505590 |
| 97 | CSK | 0.59783402 |
| 98 | TEC | 0.59082630 |
| 99 | IKBKE | 0.58453543 |
| 100 | NUAK1 | 0.58259168 |
| 101 | MAPK12 | 0.58061833 |
| 102 | ERBB3 | 0.57883593 |
| 103 | CSNK1A1L | 0.57331035 |
| 104 | BRSK2 | 0.56235715 |
| 105 | PTK2 | 0.55407073 |
| 106 | PDPK1 | 0.54378210 |
| 107 | SGK3 | 0.54212732 |
| 108 | PLK2 | 0.53598755 |
| 109 | GRK1 | 0.52514841 |
| 110 | CAMK1D | 0.52407584 |
| 111 | PRKCQ | 0.51930470 |
| 112 | PLK3 | 0.51255390 |
| 113 | NTRK2 | 0.50515624 |
| 114 | STK11 | 0.50332998 |
| 115 | MAP3K5 | 0.50192582 |
| 116 | MAP2K1 | 0.50158967 |
| 117 | CAMK1G | 0.50011704 |
| 118 | CAMK1 | 0.47615886 |
| 119 | ITK | 0.47545623 |
| 120 | PRKACA | 0.45771027 |
| 121 | TIE1 | 0.45652319 |
| 122 | STK3 | 0.44533424 |
| 123 | CDK4 | 0.43968798 |
| 124 | VRK2 | 0.43856082 |
| 125 | CDK8 | 0.42932800 |
| 126 | LATS2 | 0.42363037 |
| 127 | PLK4 | 0.41689652 |
| 128 | PBK | 0.41256816 |
| 129 | MAPK7 | 0.39891642 |
| 130 | MAP3K6 | 0.39831705 |
| 131 | NLK | 0.39549361 |
| 132 | IKBKB | 0.39109121 |
| 133 | KIT | 0.39091657 |
| 134 | CSNK1A1 | 0.38677403 |
| 135 | OBSCN | 0.38483929 |
| 136 | PDK3 | 0.38480774 |
| 137 | PDK4 | 0.38480774 |
| 138 | PRKG1 | 0.38430230 |
| 139 | FGFR3 | 0.37395402 |
| 140 | CSNK1G1 | 0.36898149 |
| 141 | IRAK1 | 0.36533893 |
| 142 | PRKG2 | 0.36366686 |
| 143 | PKN1 | 0.36300278 |
| 144 | CDK3 | 0.35053439 |
| 145 | IGF1R | 0.34118626 |
| 146 | TAOK2 | 0.34087837 |
| 147 | MST4 | 0.34087512 |
| 148 | SIK2 | 0.33229469 |
| 149 | MAP3K13 | 0.33202583 |
| 150 | EPHA4 | 0.32989256 |
| 151 | CHUK | 0.32855246 |
| 152 | TRPM7 | 0.32082492 |
| 153 | SGK2 | 0.31890918 |
| 154 | CAMKK1 | 0.31355391 |
| 155 | MTOR | 0.31079330 |
| 156 | EGFR | 0.30531672 |
| 157 | PDK1 | 0.30206115 |
| 158 | CAMK4 | 0.29697772 |
| 159 | BLK | 0.29466045 |
| 160 | CDK19 | 0.29343001 |
| 161 | CHEK2 | 0.29124587 |
| 162 | CSF1R | 0.28913183 |
| 163 | MAP3K2 | 0.28617754 |
| 164 | PIK3CA | 0.28168235 |
| 165 | TGFBR2 | 0.27681085 |
| 166 | PRKCG | 0.27572245 |
| 167 | NEK2 | 0.27458205 |
| 168 | PRKCA | 0.27240611 |
| 169 | BMX | 0.23568712 |
| 170 | ICK | 0.22963717 |
| 171 | PAK3 | 0.21643886 |
| 172 | MAP3K1 | 0.20617770 |
| 173 | ABL1 | 0.19018112 |
| 174 | MAP3K8 | 0.17522690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43391239 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42848285 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31335976 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23657851 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.00150649 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71059936 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.67517747 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62683244 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53943651 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53649109 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.51119978 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47074175 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44176149 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.33739988 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28935577 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25006688 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20461983 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06093812 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05371171 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.03747098 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.03098029 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02629483 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98504325 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.97452699 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97170810 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.91977919 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91459675 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88143026 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80232054 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.79538392 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78372425 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74432852 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.73779651 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73694348 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72554530 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70031700 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.67451956 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64329991 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.61723978 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61064744 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.60046358 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55700516 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.55536419 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51846149 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45590529 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 1.44646491 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43058582 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41150458 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39545022 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39078697 |
| 51 | Morphine addiction_Homo sapiens_hsa05032 | 1.38725292 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37607362 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37254826 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36283262 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33255448 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31086981 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28764216 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27349079 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26230194 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 1.25850248 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.25154296 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.25059263 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23360186 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.22767139 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20114294 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 1.20068620 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19275364 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17378591 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17051406 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 1.16640026 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 1.14017984 |
| 72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.12833691 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11851081 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11056759 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09408747 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08920815 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.07474834 |
| 78 | Asthma_Homo sapiens_hsa05310 | 1.02162453 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01465248 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01015940 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.95652039 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95271265 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93300614 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93137340 |
| 85 | Salivary secretion_Homo sapiens_hsa04970 | 0.89661891 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88090549 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.84467731 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82594954 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82592951 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81653422 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81457725 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79877267 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76315167 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.73803135 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70203093 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69905752 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69733063 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67073513 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64951616 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62367513 |
| 101 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61807453 |
| 102 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.60213732 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57484737 |
| 104 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55601291 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55593587 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54126989 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53661425 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.51153187 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49046824 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47947138 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46185631 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45387841 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45276345 |
| 114 | Purine metabolism_Homo sapiens_hsa00230 | 0.44122520 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44044268 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40151319 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38469686 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37744908 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.36586938 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36231594 |
| 121 | Allograft rejection_Homo sapiens_hsa05330 | 0.35646973 |
| 122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34512015 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34132886 |
| 124 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34044185 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29474241 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29427077 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.18683577 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18013886 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17029520 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13946653 |
| 131 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07923877 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04270585 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | -0.2107884 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2003831 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1930383 |
| 136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1906993 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1869299 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1823160 |
| 139 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1777812 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1700227 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | -0.1623723 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1505239 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1383058 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1363727 |
| 145 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1320756 |
| 146 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0988423 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0923514 |
| 148 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0785198 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0707611 |
| 150 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0481583 |
| 151 | Mineral absorption_Homo sapiens_hsa04978 | -0.0195824 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0113663 |

